Hamlet Protein invests in new US manufacturing plant
New production facility to begin operations in 2012
Danish-based Hamlet Protein has made a multi-million dollar investment in a new U.S. sales and production company on the back of strong sales growth in the North American market.
Employing an initial 25 members of staff, the U.S. organization based in Findlay, Ohio, will be responsible for serving customers in the entire NAFTA region. The significant expansion of overall production capacity that will result from the new production plant is consistent with Hamlet Protein's global expansion strategy, according to the company. “So far we have focused mainly on piglet feed, and we have experienced a high level of acceptance of our proteins in North America," said CEO Søren Munch. "With the trend we see in the market, we are confident that our timing is right."
The plant is expected to go into operation in early 2012.